Oxford Nanopore Raises £25M to Support Sequencing Platform Development

Funding Rounds

Summary

The fundraising means investor IP Group has increased its stake in Oxford Nanopore to 21.5%. The firm’s modular GridION platform technology includes an instrument reader and consumables based on a sensor chip containing multiple microwells. Each well represents a single addressable electronic channel and each nanopore is capable of individual identification of analyte molecules. To this end the firm recently negotiated exclusive rights to Harvard University’s graphene technology for applications in nucleic acid sequencing. The agreement covers the use of graphene for analyzing DNA and RNA, and it builds on an existing nanopore sensing collaboration between the two organizations.

$ Funding

$
Amount $41.2M Total raised
Date April 26, 2011 Announcement date
Investors Invesco, Lansdowne Partners, IP Group Lead investors
Company http://www.nanoporetech.com Funded company

Classifications

industries
No industries detected
applications
Data Management

AskAI Classifications

Labels
Biotechnology Software SaaS

Linked Companies